mutares confirms excellent operational performance
The mutares Group (ISIN: DE000A0SMSH2) closed the first half of 2015 with significant organic growth in revenues and a clear increase in profitability. Today’s publication of mutares Group’s Interim Report 2015 will be accompanied by a conference call for analysts and investors. Albeit the deconsolidation of the portfolio companies CGVL and Suir Pharma, mutares has […]